Clinico-Molecular Characteristics and Prognostic Outcomes of TP53 Mutated Patients with Advanced Non-Small Cell Lung Cancer

被引：0
|
作者：
Song, Z. [1 ]
Hu, L. [1 ]
Han, Q. [1 ]
Wang, X. [1 ]
Huo, Y. [1 ]
Jiao, T. [1 ]
Ren, G. [1 ]
Wang, K. [1 ]
Yin, B. [1 ]
Jia, Y. [1 ]
Song, J. [1 ]
Cheng, H. [2 ]
Wang, H. [2 ]
Lou, F. [2 ]
Cao, S. [2 ]
Zang, A. [1 ]
机构：
[1] Hebei Univ, Affiliated Hosp, Baoding, Peoples R China
[2] Acornmed Biotechnol Co Ltd, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
D O I：
10.1016/j.jtho.2019.08.1388
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-45
引用
收藏
页码：S656 / S656
页数：1
相关论文
共 50 条
  • [1] Mutated TP53 prevalence in EGFR-mutated advanced non-small cell lung cancer patients with brain metastases
    Stensgaard, Simone
    Eide, Inger Johanne Z.
    Stensland, Elin Marie
    Helland, Aslaug
    Ekman, Simon
    Hansen, Karin H.
    Cicenas, Saulius
    Gronberg, Bjorn Henning
    Meldgaard, Peter
    Sorensen, Boe S.
    Brustugun, Odd Terje
    CANCER RESEARCH, 2024, 84 (06)
  • [2] The clinical features and prognostic implications of the co-mutated TP53 gene in advanced non-small cell lung cancer
    Bai, Bing
    An, Xia
    Qu, Qinghui
    Liu, Xin
    Liu, Yuanyuan
    Wei, Li
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (12): : 3236 - 3245
  • [3] Prognostic and predictive effects of TP53 mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC).
    Labbe, Catherine
    Korpanty, Grzegorz
    Tomasini, Pascale
    Doherty, Mark
    Mascaux, Celine
    Jao, Kevin
    Pitcher, Bethany
    Pintilie, Melania
    Leighl, Natasha B.
    Feld, Ronald
    Liu, Geoffrey
    Bradbury, Penelope Ann
    Kamel-Reid, Suzanne
    Tsao, Ming Sound
    Shepherd, Frances A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] Prognostic Value of TP53 Hot Exon Mutation in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
    He, Y.
    Guo, R.
    Liu, Y.
    Xu, F.
    Wang, Y.
    Cao, J.
    Wu, Q.
    Han, Z.
    Ye, J.
    Zhang, L.
    Mao, X.
    Zhang, Z.
    Liu, J.
    Zhang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S681 - S682
  • [5] Association of TP53 mutation status with clinical outcomes in patients with EGFR mutated non-small cell lung cancer (NSCLC)
    Ahmed, Saman
    Aggarwal, Charu
    Mick, Rosemarie
    Bauml, Joshua
    Cohen, Roger
    Kadauke, Stephan
    Sterlicchi, Trisha
    Evans, Tracey L.
    Kucharczuk, John C.
    Desphande, Charu
    Morrissette, Jennifer J. D.
    Daber, Robert
    Langer, Corey J.
    CANCER RESEARCH, 2015, 75
  • [6] TP53 Mutations in Korean Patients with Non-small Cell Lung Cancer
    Lee, Eung Bae
    Jin, Guang
    Lee, Shin Yup
    Park, Ji Young
    Kim, Min Jung
    Choi, Jin Eun
    Jeon, Hyo Sung
    Cha, Seung Ick
    Cho, Sukki
    Kim, Chang Ho
    Park, Tae-In
    Jung, Tae Hoon
    Son, Ji-Woong
    Park, Jae Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (05) : 698 - 705
  • [7] Clinico-molecular characteristics of Chinese primary non-small cell lung cancer patients with compound EGFR mutations
    Duan, J.
    Bai, H.
    Wang, X.
    Wan, R.
    Cheng, H.
    Wang, H.
    Lou, F.
    Cao, S.
    Wang, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [8] Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC)
    Labbe, Catherine
    Cabanero, Michael
    Korpanty, Grzegorz J.
    Tomasini, Pascale
    Doherty, Mark K.
    Mascaux, Celine
    Jao, Kevin
    Pitcher, Bethany
    Wang, Rick
    Pintilie, Melania
    Leighl, Natasha B.
    Feld, Ronald
    Liu, Geoffrey
    Bradbury, Penelope Ann
    Kamel-Reid, Suzanne
    Tsao, Ming-Sound
    Shepherd, Frances A.
    LUNG CANCER, 2017, 111 : 23 - 29
  • [9] Exploring the utility of TP53 mutations as prognostic markers in patients with non-small cell lung cancer (NSCLC)
    Wang, Y.
    Zuo, J.
    Feng, L.
    Fan, Z.
    Wang, L.
    Zhang, X.
    Han, J.
    Zhou, X.
    Ye, J.
    Li, B.
    Lizaso, A.
    Zhou, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S799 - S800
  • [10] Effect of TP53 Variants in HER2-mutated Non-Small Cell Lung Cancer (NSCLC)
    Feng, J.
    Hueniken, K.
    Fan, Z. J.
    Corke, L.
    Leighl, N. B.
    Liu, G.
    Bradbury, P. A.
    Sacher, A.
    Eng, L.
    Stockley, T.
    Tsao, M. S.
    Shepherd, F.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S343 - S344
12345